Watch out for this fellow:
GENERAL NEWS:
Stocks recovered from initial weakness and moved mostly higher over the course of morning trading on Wednesday but came under significant pressure in the latter part of the session. The major averages moved sharply lower in late-day trading, partly offsetting recent strength.
The major averages saw further downside going into the close, ending the session at their worst levels of the day. The Dow slumped 475.92 points or 1.3 percent to 37,082.00, the Nasdaq dove 225.28 points or 1.5 percent to 14,777.93 and the S&P 500 tumbled 70.02 points or 1.5 percent to 4,698.35.
The late-day sell-off on Wall Street was largely attributed to profit taking, with traders cashing in on the strong upward move seen in recent sessions.
The Dow and the Nasdaq closed higher for the ninth consecutive session on Tuesday, as traders continued to express optimism about the outlook for interest rates.
The upward trend lifted the Dow to new record highs, while the Nasdaq and the S&P 500 reached their best levels in nearly two years.
A steep drop by shares of FedEx (FDX) also weighed on the markets, with the delivery giant plunging by 12.1 percent on the day.
The nosedive by FedEx came after the company reported weaker than expected fiscal second quarter results and lowered its full-year revenue guidance.
Meanwhile, traders shrugged off a Conference Board showing a much bigger than expected improvement in U.S. consumer confidence, which had contributed to the rebound in early trading.
The Conference Board said its consumer confidence index jumped to 110.7 in December from a downwardly revised 101.0 in November.
Economists had expected the consumer confidence index to rise to 103.4 from the 102.0 originally reported for the previous month.
A separate report released by the National Association of Realtors showed an unexpected rebound in U.S. existing home sales in the month of November.
Sector News
Biotechnology stocks moved sharply lower over the course of the session, with the NYSE Arca Biotechnology Index plunging by 3.4 percent after ending Tuesday’s trading at a five-month closing high.
Netherlands-based Argenx (ARGX) led the sector lower, plummeting by 25.1 percent after reporting disappointing results from a late-stage trial of its therapy for an autoimmune condition that causes skin blistering.
Substantial weakness also emerged among semiconductor stocks, as reflected by the 2.9 percent slump by the Philadelphia Semiconductor Index. The index reached a record closing high on Tuesday.
Transportation stocks also saw considerable weakness amid the steep drop by the FedEx, dragging the Dow Jones Transportation Average down by 2.4 percent.
Banking, networking and gold stocks also came under pressure as the day progressed, moving lower along with most of the other major sectors.
Other Markets
In overseas trading, stock markets across the Asia-Pacific region moved mostly higher on Wednesday. Japan’s Nikkei 225 Index jumped by 1.4 percent and Hong Kong’s Hang Seng Index climbed by 0.7 percent, although China’s Shanghai Composite Index bucked the uptrend and slumped by 1.0 percent.
Meanwhile, the major European markets turned in a mixed performance. While the German DAX Index edged down by 0.1, the French CAC 40 Index crept up by 0.1 percent and the U.K.’s FTSE 100 Index jumped by 1.0 percent.
In the bond market, treasuries gave back ground after seeing initial strength but moved back to the upside in afternoon trading. As a result, the yield on the benchmark ten-year note, which moves opposite of its price, slid 4.5 basis points to 3.877 percent.
Looking Ahead
Trading on Thursday may be impacted by reaction to a slew of U.S. economic data, including reports on weekly jobless claims, Philadelphia-area manufacturing activity and leading U.S. economic indicators.
https://www.howestreet.com/
COULD SANTA CLAUS RALLY BE A GOOD SIGN FOR THE NEW YEAR?
NEXT INTERVIEW ON HOWE STREET PUBLISHED THIS WEEKEND
U.S. DOLLAR
CANADIAN DOLLAR
URANIUM – REPORTS ONLY ISSUED WEEKLY
COMMODITIES
\
https://abcnews.go.com/International/iceland-volcano-eruption-toxic-air-warning/story?id=105806785
BRICS: China & Saudi Arabia Drive Global End to US Dollar -Watcher.guru
No one knows for sure what the future holds; but if it’s the future of the US dollar, it’s probably not good. The “dedollarization” movement continues and 2024 could prove to be more than challenging for the greenback.
by Joshua Ramos
For much of the year, the BRICS bloc has seen a renewed focus on de-dollarization. Indeed, its 2023 annual summit ended with a five-nation expansion plan and several initiatives to help boost local currencies. Now, amid the expansion of the BRICS bloc, both China and Saudi Arabia are set to drive the global end to the US dollar.
Saudi Arabia was one of the five nations set to join the alliance. Specifically, it joined the United Arab Emirates (UAE), Egypt, Iran, and Ethiopia. However, the nation is poised to be of massive importance to the bloc’s efforts against the dollar. Subsequently, even a former US official has warned of what its cooperation with the initiatives could mean.
Throughout 2023, the BRICS alliance has shaken up the geopolitical sector. Indeed, the bloc has consistently challenged the status quo of the global order. Subsequently, they have driven their own goal of multipolarity in the current international landscape. Now, those two things could see continued evolution through the coming year, thanks to recent cooperation.
Specifically, the BRICS bloc is set to see both China and Saudi Arabia drive the global end to the US dollar. Indeed, the two nations have agreed to a landmark currency swap that will continue to push Saudi Arabia’s embrace of BRICS local currencies. Therefore, it will only decrease its use of the US dollar.
https://tinyurl.com/2rd9wv52
OPPORTUNITY TO ACCESS MARK LEIBOVIT’S PROPRIETARY VOLUME REVERSAL INDICATOR – THIS IS THE ONLY PLACE TO DO IT!
https://www.metastock.com/prod
COME ON, DAD. IT’S TIME TO EAT
DISCLAIMER:
WE ARE NOT FINANCIAL ADVISORS AND DO NOT PROVIDE FINANCIAL ADVICE
The website, LeibovitVRNewsletters.com, is published by LeibovitVRNewsletters LLC.
In using LeibovitVRnewsletters.com (a/k/a LeibovitVRNewsletters LLC) you agree to these Terms & Conditions governing the use of the service. These Terms & Conditions are subject to change without notice. We are publishers and are not registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority.
All stocks and ETFs discussed are HYPOTHETICAL and not actual trades whose actual execution may differ markedly from prices posted on the website and in emails. This may be due internet connectivity, quote delays, data entry errors and other market conditions. Hypothetical or simulated performance results have certain inherent limitations as to liquidity and execution among other variables. PAST RESULTS ARE NOT NECESSARILY INDICATIVE OF FUTURE FORECASTING ACCURACY OR PROFITABLE TRADING RESULTS.
All investments are subject to risk, which should be considered on an individual basis before making any investment decision. We are not responsible for errors and omissions. These publications are intended solely for information and educational purposes only and the content within is not to be construed, under any circumstances, as an offer to buy or to sell or a solicitation to buy or sell or trade in any commodities or securities named within.
All commentary is provided for educational purposes only. This material is based upon information we consider reliable. However, accuracy is not guaranteed. Subscribers should always do their own investigation before investing in any security. Furthermore, you cannot be assured that your will profit or that any losses can or will be limited. It is important to know that no guarantee of any kind is implied nor possible where projections of future conditions in the markets are attempted.
Stocks and ETFs may be held by principals of LeibovitVRNewsletters LLC whose personal investment decisions including entry and exit points may differ from guidelines posted.
LeibovitVRNewsletters.com cannot and do not assess, verify or guarantee the suitability or profitability of any particular investment. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. As an express condition of using this service and anytime after ending the service, you agree not to hold LeibovitVRNewsletters.com or any employees liable for trading losses, lost profits or other damages resulting from your use of information on the Site in any form (Web-based, email-based, or downloadable software), and you agree to indemnify and hold LeibovitVRNewsletters.com and its employees harmless from and against any and all claims, losses, liabilities, costs, and expenses (including but not limited to attorneys’ fees) arising from your violation of this agreement. This paragraph is not intended to limit rights available to you or to us that may be available under the federal securities laws.
For rights, permissions, subscription and customer service, contact the publisher at mark.vrtrader@gmail.com or call at 928-282-1275 or mail to 10632 N. Scottsdale Road B-426, Scottsdale, AZ 85254.
The Leibovit Volume Reversal, Volume Reversal and Leibovit VR are registered trademarks.
© Copyright 2023. All rights reserved.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]